Global Meningococcal Vaccine Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Meningococcal Vaccine Market
The global Meningococcal Vaccine market size is projected to reach US$ 339.2 million by 2027, from US$ 251 million in 2020, at a CAGR of 4.4% during 2021-2027.
Global Meningococcal Vaccine Scope and Segment
The global Meningococcal Vaccine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Meningococcal Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
By the end users/application, this report covers the following segments
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Competitive Landscape:
The report provides a list of all the key players in the Meningococcal Vaccine market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Meningococcal Vaccine key manufacturers in this market include:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei

TABLE OF CONTENT

1 Meningococcal Vaccine Market Overview
1.1 Meningococcal Vaccine Product Overview
1.2 Meningococcal Vaccine Market Segment by Type
1.2.1 Meningtits A
1.2.2 Polysaccharide Meningtitis AC
1.2.3 Meningitis ACYW
1.3 Global Meningococcal Vaccine Market Size by Type
1.3.1 Global Meningococcal Vaccine Market Size Overview by Type (2016-2027)
1.3.2 Global Meningococcal Vaccine Historic Market Size Review by Type (2016-2030)
1.3.2.1 Global Meningococcal Vaccine Sales Breakdown in Volume by Type (2016-2030)
1.3.2.2 Global Meningococcal Vaccine Sales Breakdown in Value by Type (2016-2030)
1.3.2.3 Global Meningococcal Vaccine Average Selling Price (ASP) by Type (2016-2030)
1.3.3 Global Meningococcal Vaccine Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Meningococcal Vaccine Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Meningococcal Vaccine Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Meningococcal Vaccine Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Meningococcal Vaccine Sales Breakdown by Type (2016-2030)
1.4.2 Europe Meningococcal Vaccine Sales Breakdown by Type (2016-2030)
1.4.3 Asia-Pacific Meningococcal Vaccine Sales Breakdown by Type (2016-2030)
1.4.4 Latin America Meningococcal Vaccine Sales Breakdown by Type (2016-2030)
1.4.5 Middle East and Africa Meningococcal Vaccine Sales Breakdown by Type (2016-2030)

2 Global Meningococcal Vaccine Market Competition by Company
2.1 Global Top Players by Meningococcal Vaccine Sales (2016-2030)
2.2 Global Top Players by Meningococcal Vaccine Revenue (2016-2030)
2.3 Global Top Players Meningococcal Vaccine Price (2016-2030)
2.4 Global Top Manufacturers Meningococcal Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Meningococcal Vaccine Market Competitive Situation and Trends
2.5.1 Meningococcal Vaccine Market Concentration Rate (2016-2030)
2.5.2 Global 5 and 10 Largest Manufacturers by Meningococcal Vaccine Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2020)
2.7 Date of Key Manufacturers Enter into Meningococcal Vaccine Market
2.8 Key Manufacturers Meningococcal Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Meningococcal Vaccine Status and Outlook by Region
3.1 Global Meningococcal Vaccine Market Size and CAGR by Region: 2016 VS 2030 VS 2026
3.2 Global Meningococcal Vaccine Historic Market Size by Region
3.2.1 Global Meningococcal Vaccine Sales in Volume by Region (2016-2030)
3.2.2 Global Meningococcal Vaccine Sales in Value by Region (2016-2030)
3.2.3 Global Meningococcal Vaccine Sales (Volume & Value) Price and Gross Margin (2016-2030)
3.3 Global Meningococcal Vaccine Forecasted Market Size by Region
3.3.1 Global Meningococcal Vaccine Sales in Volume by Region (2022-2027)
3.3.2 Global Meningococcal Vaccine Sales in Value by Region (2022-2027)
3.3.3 Global Meningococcal Vaccine Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Meningococcal Vaccine by Application
4.1 Meningococcal Vaccine Market Segment by Application
4.1.1 6 Months-15Year
4.1.2 over 3 Year
4.1.3 over 2 Year
4.1.4 over 3 Months
4.2 Global Meningococcal Vaccine Market Size by Application
4.2.1 Global Meningococcal Vaccine Market Size Overview by Application (2016-2027)
4.2.2 Global Meningococcal Vaccine Historic Market Size Review by Application (2016-2030)
4.2.2.1 Global Meningococcal Vaccine Sales Breakdown in Volume, by Application (2016-2030)
4.2.2.2 Global Meningococcal Vaccine Sales Breakdown in Value, by Application (2016-2030)
4.2.2.3 Global Meningococcal Vaccine Average Selling Price (ASP) by Application (2016-2030)
4.2.3 Global Meningococcal Vaccine Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Meningococcal Vaccine Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Meningococcal Vaccine Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Meningococcal Vaccine Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Meningococcal Vaccine Sales Breakdown by Application (2016-2030)
4.3.2 Europe Meningococcal Vaccine Sales Breakdown by Application (2016-2030)
4.3.3 Asia-Pacific Meningococcal Vaccine Sales Breakdown by Application (2016-2030)
4.3.4 Latin America Meningococcal Vaccine Sales Breakdown by Application (2016-2030)
4.3.5 Middle East and Africa Meningococcal Vaccine Sales Breakdown by Application (2016-2030)

5 North America Meningococcal Vaccine by Country
5.1 North America Meningococcal Vaccine Historic Market Size by Country
5.1.1 North America Meningococcal Vaccine Sales in Volume by Country (2016-2030)
5.1.2 North America Meningococcal Vaccine Sales in Value by Country (2016-2030)
5.2 North America Meningococcal Vaccine Forecasted Market Size by Country
5.2.1 North America Meningococcal Vaccine Sales in Volume by Country (2022-2027)
5.2.2 North America Meningococcal Vaccine Sales in Value by Country (2022-2027)

6 Europe Meningococcal Vaccine by Country
6.1 Europe Meningococcal Vaccine Historic Market Size by Country
6.1.1 Europe Meningococcal Vaccine Sales in Volume by Country (2016-2030)
6.1.2 Europe Meningococcal Vaccine Sales in Value by Country (2016-2030)
6.2 Europe Meningococcal Vaccine Forecasted Market Size by Country
6.2.1 Europe Meningococcal Vaccine Sales in Volume by Country (2022-2027)
6.2.2 Europe Meningococcal Vaccine Sales in Value by Country (2022-2027)

7 Asia-Pacific Meningococcal Vaccine by Region
7.1 Asia-Pacific Meningococcal Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Meningococcal Vaccine Sales in Volume by Region (2016-2030)
7.1.2 Asia-Pacific Meningococcal Vaccine Sales in Value by Region (2016-2030)
7.2 Asia-Pacific Meningococcal Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Meningococcal Vaccine Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Meningococcal Vaccine Sales in Value by Region (2022-2027)

8 Latin America Meningococcal Vaccine by Country
8.1 Latin America Meningococcal Vaccine Historic Market Size by Country
8.1.1 Latin America Meningococcal Vaccine Sales in Volume by Country (2016-2030)
8.1.2 Latin America Meningococcal Vaccine Sales in Value by Country (2016-2030)
8.2 Latin America Meningococcal Vaccine Forecasted Market Size by Country
8.2.1 Latin America Meningococcal Vaccine Sales in Volume by Country (2022-2027)
8.2.2 Latin America Meningococcal Vaccine Sales in Value by Country (2022-2027)

9 Middle East and Africa Meningococcal Vaccine by Country
9.1 Middle East and Africa Meningococcal Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Meningococcal Vaccine Sales in Volume by Country (2016-2030)
9.1.2 Middle East and Africa Meningococcal Vaccine Sales in Value by Country (2016-2030)
9.2 Middle East and Africa Meningococcal Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Meningococcal Vaccine Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Meningococcal Vaccine Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Meningococcal Vaccine Business
10.1 Novartis
10.1.1 Novartis Corporation Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.1.4 Novartis Meningococcal Vaccine Products Offered
10.1.5 Novartis Recent Development
10.2 GSK
10.2.1 GSK Corporation Information
10.2.2 GSK Introduction and Business Overview
10.2.3 GSK Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.2.4 GSK Meningococcal Vaccine Products Offered
10.2.5 GSK Recent Development
10.3 Merck
10.3.1 Merck Corporation Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.3.4 Merck Meningococcal Vaccine Products Offered
10.3.5 Merck Recent Development
10.4 CSL
10.4.1 CSL Corporation Information
10.4.2 CSL Introduction and Business Overview
10.4.3 CSL Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.4.4 CSL Meningococcal Vaccine Products Offered
10.4.5 CSL Recent Development
10.5 Baxter
10.5.1 Baxter Corporation Information
10.5.2 Baxter Introduction and Business Overview
10.5.3 Baxter Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.5.4 Baxter Meningococcal Vaccine Products Offered
10.5.5 Baxter Recent Development
10.6 JN International Medical Corporation
10.6.1 JN International Medical Corporation Corporation Information
10.6.2 JN International Medical Corporation Introduction and Business Overview
10.6.3 JN International Medical Corporation Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.6.4 JN International Medical Corporation Meningococcal Vaccine Products Offered
10.6.5 JN International Medical Corporation Recent Development
10.7 Serum Institute of India
10.7.1 Serum Institute of India Corporation Information
10.7.2 Serum Institute of India Introduction and Business Overview
10.7.3 Serum Institute of India Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.7.4 Serum Institute of India Meningococcal Vaccine Products Offered
10.7.5 Serum Institute of India Recent Development
10.8 Bio-Med
10.8.1 Bio-Med Corporation Information
10.8.2 Bio-Med Introduction and Business Overview
10.8.3 Bio-Med Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.8.4 Bio-Med Meningococcal Vaccine Products Offered
10.8.5 Bio-Med Recent Development
10.9 China National Biotec Group
10.9.1 China National Biotec Group Corporation Information
10.9.2 China National Biotec Group Introduction and Business Overview
10.9.3 China National Biotec Group Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.9.4 China National Biotec Group Meningococcal Vaccine Products Offered
10.9.5 China National Biotec Group Recent Development
10.10 Hualan Bio
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Meningococcal Vaccine Product Category, Application and Specification
10.10.3 Hualan Bio Meningococcal Vaccine Sales, Revenue, Price and Gross Margin (2016-2030)
10.10.4 Main Business Overview
10.10.5 Hualan Bio Recent Development
10.11 Walvax
10.11.1 Walvax Corporation Information
10.11.2 Walvax Introduction and Business Overview
10.11.3 Walvax Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.11.4 Walvax Meningococcal Vaccine Products Offered
10.11.5 Walvax Recent Development
10.12 Zhifei
10.12.1 Zhifei Corporation Information
10.12.2 Zhifei Introduction and Business Overview
10.12.3 Zhifei Meningococcal Vaccine Sales, Revenue and Gross Margin (2016-2030)
10.12.4 Zhifei Meningococcal Vaccine Products Offered
10.12.5 Zhifei Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Meningococcal Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Meningococcal Vaccine Industrial Chain Analysis
11.4 Meningococcal Vaccine Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Meningococcal Vaccine Distributors
12.3 Meningococcal Vaccine Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Choose License Type

Checkout Inquiry Sample